Published in J Immunol on November 19, 2014
Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology. MBio (2015) 0.98
Azacytidine treatment inhibits the progression of Herpes Stromal Keratitis by enhancing regulatory T cell function. J Virol (2017) 0.79
IL-2 complex treatment amplifies CD8(+) T cell mediated immunity following herpes simplex virus-1 infection. Microbes Infect (2016) 0.75
Loss of Neurokinin-1 Receptor Alters Ocular Surface Homeostasis and Promotes an Early Development of Herpes Stromal Keratitis. J Immunol (2016) 0.75
Virus infection drives IL-2 antibody complexes into pro-inflammatory agonists in mice. Sci Rep (2016) 0.75
Challenges of corneal infections. Expert Rev Ophthalmol (2016) 0.75
The function of regulatory T cells at the ocular surface: Review. Ocul Surf (2017) 0.75
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol (2006) 14.33
Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity (2008) 9.82
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol (2009) 8.65
The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol (2009) 8.32
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med (2007) 7.73
Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol (2005) 7.44
Natural regulatory T cells in infectious disease. Nat Immunol (2005) 6.49
Coordination of early protective immunity to viral infection by regulatory T cells. Science (2008) 5.33
Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol (2006) 4.04
In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med (2009) 3.78
Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med (2006) 3.57
CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol (2004) 3.06
Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med (2005) 2.61
Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med (2010) 2.35
On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol (1997) 2.14
CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol (2003) 2.11
Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol (1992) 1.92
Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node. J Exp Med (2005) 1.88
Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol (2006) 1.73
Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest (2003) 1.62
Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells. J Immunol (2008) 1.58
LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci U S A (1997) 1.58
Herpes keratitis. Prog Retin Eye Res (2012) 1.55
Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J Immunol (2011) 1.53
Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J Clin Invest (2010) 1.50
CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. Cancer Res (2012) 1.34
Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis. J Virol (1998) 1.33
Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J Immunol (2008) 1.26
Control of stromal keratitis by inhibition of neovascularization. Am J Pathol (2001) 1.24
In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions. J Virol (2008) 1.16
Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. Circulation (2012) 1.15
Early responding dendritic cells direct the local NK response to control herpes simplex virus 1 infection within the cornea. J Immunol (2011) 1.14
IFN-α-driven CCL2 production recruits inflammatory monocytes to infection site in mice. Mucosal Immunol (2012) 1.11
CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J Immunol (2004) 1.11
Application of IL-2 therapy to target T regulatory cell function. Trends Immunol (2012) 1.11
Regulatory T cell migration during an immune response. Trends Immunol (2012) 1.10
CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur J Immunol (2006) 1.06
Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. PLoS Pathog (2011) 1.04
Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. J Leukoc Biol (2006) 1.04
CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis. J Immunol (2012) 0.96
A Functional Type I Interferon Pathway Drives Resistance to Cornea Herpes Simplex Virus Type 1 Infection by Recruitment of Leukocytes. J Biomed Res (2011) 0.95
MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis. Mol Cells (2008) 0.92
CD4(+) and CD8(+) cells are key participants in the development of recurrent herpetic stromal keratitis in mice. Microb Pathog (2002) 0.91
TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions. J Virol (2012) 0.87
Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. Front Physiol (2014) 0.84
The suppressive effect of CD25+Treg cells on Th1 differentiation requires cell-cell contact partially via TGF-β production. Cell Biol Int (2011) 0.83
Immunological aspects of herpetic stromal keratitis. Semin Ophthalmol (2008) 0.82
IL-2/anti-IL-2 complex: a novel strategy of in vivo regulatory T cell expansion in renal injury. J Am Soc Nephrol (2013) 0.77